Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

NCT03858972 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

152

Enrollment

INDUSTRY

Sponsor class

Stopped The Sponsor has discontinued the development of tesetaxel

Conditions

Breast Cancer

Interventions

DRUG: Tesetaxel
DRUG: Capecitabine

Sponsor

Odonate Therapeutics, Inc.